A lawsuit filed against Johnson & Johnson over the link between the company’s talcum powder products and an increased risk of ovarian cancer is scheduled to go to trial in February 2017, a Missouri judge has ruled. The lawsuit – which involves the cases of six women who were diagnosed with ovarian cancer after years of using Johnson & Johnson baby powder products for feminine hygiene – is scheduled to go to trial on February 21, 2017 in a St. Louis, Missouri court.
Johnson & Johnson is currently facing about 1,800 lawsuits filed by women who were diagnosed with ovarian cancer after using the company’s talcum powder products for feminine hygiene. These lawsuits include about 1,200 cases against the company filed in Missouri federal court, as well as an additional 600 lawsuits facing Johnson & Johnson in New Jersey state court.
Although warnings about the link between talcum powder and ovarian cancer have only recently come to the attention of many women, the lawsuits against Johnson & Johnson have alleged that the company has known for years about the link between its baby powder products and an increased cancer risk. The lawsuits have also alleged that Johnson & Johnson continued marketing its talcum baby powder products – including Johnson’s Baby Powder, Shower to Shower, and other products – for years in spite of its knowledge about the ovarian cancer risk they could pose.
The two verdicts issued so far in the Missouri talcum powder lawsuits against Johnson & Johnson have resulted in multimillion dollar verdicts against the pharmaceutical giant. In February 2016, a St. Louis jury awarded $72 million in damages to the family of an Alabama woman who died from ovarian cancer after years of using Johnson’s Baby Powder, Shower to Shower, and other talcum powder products sold by Johnson & Johnson for feminine hygiene. In April 2016, another jury awarded $55 million in damages to a woman who was diagnosed with ovarian cancer and underwent a hysterectomy after using Johnson & Johnson talcum baby powder products.
Multiple studies have established scientific evidence of a link between the use of talcum baby powder and ovarian cancer risks. In 2013, a study published in the journal Cancer Prevention Research found that women who used talcum powder products for feminine hygiene in the vaginal area were 20-30% more likely to develop ovarian cancer than non-users. Another study published in 2016 found that the use of talcum powder for feminine hygiene was associated with a 33% increased risk of developing ovarian cancer.
Consumers who have been diagnosed with ovarian cancer or other forms of cancer linked to the use of talcum powder products may be eligible to file a lawsuit and pursue compensation for their injuries. The first step in taking legal action is to speak with a law firm whose attorneys have the knowledge and years of experience with product liability litigation in order to successfully handle your case from start to finish.
The lawyers at Heygood, Orr & Pearson have filed numerous product liability lawsuits on behalf of our clients, including cases involving defective drugs, dangerous medical devices, and other commercial products. We are currently representing dozens of women who have contracted ovarian cancer following long-term exposure to talcum baby powder.
The attorneys at Heygood, Orr & Pearson have taken on some of the largest companies in the world to ensure that our clients achieve a fair result in their case. Our firm is dedicated to the belief that all consumers should have the right to experienced and qualified legal counsel to ensure that their interests are represented and that their rights are fully protected.
For more information about the link between talcum baby powder products and ovarian cancer and to find out more about whether you may qualify to file a lawsuit, contact the lawyers at Heygood, Orr & Pearson for a free legal consultation. To speak with an attorney about your legal rights, please call us toll-free at 1-877-446-9001, or simply follow the link to our free case evaluation form and answer a few simple questions about your case to get started.